{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":17,"n_cols":5,"rows_kept":17,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[13,2,13,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910150285003321"]
[null,null,"Autore",null,"Cheong Chi Mo"]
[null,null,"Titolo",null,"L'acces Universel Aux Medicaments Et Les ADPIC: 1994 - 2014"]
[null,null,"Pubbl/distr/stampa",null,"Editions L'Harmattan"]
[null,null,"ISBN",null,"2-336-76758-9"]
[{"$nulls":4},"2-14-001522-3"]
[null,null,"Descrizione fisica",null,"1 online resource (254 p.)"]
[null,null,"Soggetti",null,"Drug accessibility - Law and legislation"]
[{"$nulls":4},"Drugs - Law and legislation"]
[{"$nulls":4},"Drugs"]
[{"$nulls":4},"Pharmaceutical policy"]
[{"$nulls":4},"Medical economics - Corrupt practices"]
[{"$nulls":4},"Right to health"]
[null,null,"Lingua di pubblicazione",null,"Francese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","Vingt ans apres la ratification de l'Accord des Aspects des Droits de la Propriete Intellectuelle qui touchent au Commerce (ADPIC) par l'ensemble des Etats membres de l'OMC, il convient de faire le bilan de cet instrument juridique international dans son application a la production pharmaceutique. Cet accord devait permettre la promotion de la recherche et du developpement de nouveaux medicaments, tout en assurant leur acces universel. Que pourrions-nous faire pour assurer l'acces universel aux medicaments ?"]